These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
606 related articles for article (PubMed ID: 24267474)
21. Cyclophosphamide pulse therapy followed by azathioprine or methotrexate induces long-term remission in patients with steroid-refractory Crohn's disease. Schmidt C; Wittig BM; Moser C; Zeitz M; Stallmach A Aliment Pharmacol Ther; 2006 Jul; 24(2):343-50. PubMed ID: 16842461 [TBL] [Abstract][Full Text] [Related]
22. Current relevance of pharmacogenetics in immunomodulation treatment for Crohn's disease. Roberts RL; Barclay ML J Gastroenterol Hepatol; 2012 Oct; 27(10):1546-54. PubMed ID: 22741564 [TBL] [Abstract][Full Text] [Related]
23. Medical management of Crohn's disease. Cottone M; Renna S; Orlando A; Mocciaro F Expert Opin Pharmacother; 2011 Nov; 12(16):2505-25. PubMed ID: 21988215 [TBL] [Abstract][Full Text] [Related]
24. Adverse events associated with common therapy regimens for moderate-to-severe Crohn's disease. Marehbian J; Arrighi HM; Hass S; Tian H; Sandborn WJ Am J Gastroenterol; 2009 Oct; 104(10):2524-33. PubMed ID: 19532125 [TBL] [Abstract][Full Text] [Related]
25. Canadian Association of Gastroenterology Clinical Practice Guideline for the Medical Management of Pediatric Luminal Crohn's Disease. Mack DR; Benchimol EI; Critch J; deBruyn J; Tse F; Moayyedi P; Church P; Deslandres C; El-Matary W; Huynh H; Jantchou P; Lawrence S; Otley A; Sherlock M; Walters T; Kappelman MD; Sadowski D; Marshall JK; Griffiths A Gastroenterology; 2019 Aug; 157(2):320-348. PubMed ID: 31320109 [TBL] [Abstract][Full Text] [Related]
26. 6-Mercaptopurine/Azathioprine remains an important contributor in managing Crohn's disease. Korelitz BI; Present DH J Crohns Colitis; 2014 Aug; 8(8):735-8. PubMed ID: 24462321 [TBL] [Abstract][Full Text] [Related]
27. [Adalimumab vasculitis in a patient with Crohn's disease]. Muñoz Villafranca C; Izu Belloso RM; Bravo Rodriguez MT; Basterra Olabarrieta S Gastroenterol Hepatol; 2013 Apr; 36(4):296-7. PubMed ID: 23522950 [No Abstract] [Full Text] [Related]
28. Therapeutic efficacy and safety of 6-mercaptopurine and azathioprine in patients with Crohn's disease. Markowitz JF Rev Gastroenterol Disord; 2003; 3 Suppl 1():S23-9. PubMed ID: 12684586 [TBL] [Abstract][Full Text] [Related]
29. The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in inflammatory bowel disease. Orlando A; Armuzzi A; Papi C; Annese V; Ardizzone S; Biancone L; Bortoli A; Castiglione F; D'Incà R; Gionchetti P; Kohn A; Poggioli G; Rizzello F; Vecchi M; Cottone M; ; Dig Liver Dis; 2011 Jan; 43(1):1-20. PubMed ID: 20843756 [TBL] [Abstract][Full Text] [Related]
30. The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response? D'Haens GR; Panaccione R; Higgins PD; Vermeire S; Gassull M; Chowers Y; Hanauer SB; Herfarth H; Hommes DW; Kamm M; Löfberg R; Quary A; Sands B; Sood A; Watermeyer G; Lashner B; Lémann M; Plevy S; Reinisch W; Schreiber S; Siegel C; Targan S; Watanabe M; Feagan B; Sandborn WJ; Colombel JF; Travis S Am J Gastroenterol; 2011 Feb; 106(2):199-212; quiz 213. PubMed ID: 21045814 [TBL] [Abstract][Full Text] [Related]
32. Optimum duration of treatment with 6-mercaptopurine for Crohn's disease. Kim PS; Zlatanic J; Korelitz BI; Gleim GW Am J Gastroenterol; 1999 Nov; 94(11):3254-7. PubMed ID: 10566725 [TBL] [Abstract][Full Text] [Related]
33. [A Case of Crohn's Disease Showing Favorable Response to Induction and Maintenance Therapy with Methotrexate after Failure of Anti-tumor Necrosis Factor Therapy]. Choi JR; Yun GW; Park YM; Kim JH; Youn YH; Park HJ; Park JJ Korean J Gastroenterol; 2015 Oct; 66(4):231-6. PubMed ID: 26493510 [TBL] [Abstract][Full Text] [Related]
34. Immunosuppressive therapy of inflammatory bowel disease: a historical perspective. Korelitz BI Gastroenterologist; 1995 Jun; 3(2):141-52. PubMed ID: 7640945 [TBL] [Abstract][Full Text] [Related]
35. [Immunosuppressive treatment and Crohn's disease]. Delwaide J; Louis E; Gast P; Belaiche J Rev Med Liege; 1991 Jan; 46(1):22-8. PubMed ID: 2011678 [No Abstract] [Full Text] [Related]
36. Parenteral Methotrexate Is Efficient in the Treatment of Azathioprine Refractory Crohn's Disease. Gökbulut V; Özin Y; Kalkan İH; Arı D; Yüksel M; Kılıç ZMY; Kayaçetin E Turk J Gastroenterol; 2022 Feb; 33(2):111-118. PubMed ID: 35115294 [TBL] [Abstract][Full Text] [Related]
38. Methotrexate following unsuccessful thiopurine therapy in pediatric Crohn's disease. Turner D; Grossman AB; Rosh J; Kugathasan S; Gilman AR; Baldassano R; Griffiths AM Am J Gastroenterol; 2007 Dec; 102(12):2804-12; quiz 2803, 2813. PubMed ID: 18042110 [TBL] [Abstract][Full Text] [Related]
39. [A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators]. Martreau P Gastroenterol Clin Biol; 2000 Dec; 24(12):1243-4. PubMed ID: 11277090 [No Abstract] [Full Text] [Related]
40. Thiopurines are associated with a reduction in surgical re-resections in patients with Crohn's disease: a long-term follow-up study in a regional and academic cohort. van Loo ES; Vosseberg NW; van der Heide F; Pierie JP; van der Linde K; Ploeg RJ; Dijkstra G; Nieuwenhuijs VB Inflamm Bowel Dis; 2013 Dec; 19(13):2801-8. PubMed ID: 24189041 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]